Li, X.; Liu, X.; Mao, J.; Liu, D.; Jiao, Z.
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients. Pharmaceutics 2024, 16, 1145.
https://doi.org/10.3390/pharmaceutics16091145
AMA Style
Li X, Liu X, Mao J, Liu D, Jiao Z.
Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients. Pharmaceutics. 2024; 16(9):1145.
https://doi.org/10.3390/pharmaceutics16091145
Chicago/Turabian Style
Li, Xiping, Xiaoqin Liu, Juehui Mao, Dong Liu, and Zheng Jiao.
2024. "Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients" Pharmaceutics 16, no. 9: 1145.
https://doi.org/10.3390/pharmaceutics16091145
APA Style
Li, X., Liu, X., Mao, J., Liu, D., & Jiao, Z.
(2024). Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients. Pharmaceutics, 16(9), 1145.
https://doi.org/10.3390/pharmaceutics16091145